Publications by authors named "Kurt Possinger"

Claim this Profile
A
ACT-FASTER, a Prospective Cohort Study Exploring Treatment Patterns with Fulvestrant and Exemestane in Postmenopausal Patients with Advanced Hormone Receptor-Positive Breast Cancer under Real-Life Conditions in Germany.
Nicolai Maass, Helmut Ostermann, Kurt Possinger, Peter Klein, Hans Tesch

Breast Care (Basel)· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumor Cell-selective Synergism of TRAIL- and ATRA-induced Cytotoxicity in Breast Cancer Cells.
Annekathrin Reinhardt, Hongyu Liu, Yunxia Ma, Yongan Zhou, Chuanbing Zang, Kurt Possinger

Anticancer Res· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pretreatment of BMSCs with TZD solution decreases the proliferation rate of MCF‑7 cells by reducing FGF4 protein expression.
Boon-Yin Khoo, Kalpanah Nadarajan, Siang-Yian Shim, Noorizan Miswan, Chuan-Bing Zang, Kurt Possinger

Mol Med Rep· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cisplatin Plus Ifosfamide with/without Etoposide as Salvage Treatment in Heavily-pre-treated Patients with Metastatic Breast Cancer.
Piet Habbel, Annika Kurreck, Carsten-Oliver Schulz, Anne Constanze Regierer, David Kaul, Kurt Possinger

Anticancer Res· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of primary breast cancer at the surgical unit of the Charité 1984-1998.
Klaus-Jürgen Winzer, Anika Buchholz, Hans Guski, Hans-Dieter Frohberg, Felix Diekmann, Kurt Possinger

Onkologie· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of pan-class I phosphatidyl-inositol-3-kinase by NVP-BKM120 effectively blocks proliferation and induces cell death in diffuse large B-cell lymphoma.
Chuanbing Zang, Jan Eucker, Hongyu Liu, Annekatrin Coordes, Minoo Lenarz, Kurt Possinger

Leuk Lymphoma· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent inhibition of PI3-kinase and mTOR induces cell death in diffuse large B cell lymphomas, a mechanism involving down regulation of Mcl-1.
Chuanbing Zang, Jan Eucker, Hongyu Liu, Anja Müller, Kurt Possinger

Cancer Lett· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of CYP2D6-genotype on tamoxifen efficacy in advanced breast cancer.
Jennifer Karle, Juliane Bolbrinker, Silvia Vogl, Reinhold Kreutz, Carsten Denkert, Kurt Possinger

Breast Cancer Res Treat· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
13th st. Gallen international breast cancer conference 2013: primary therapy of early breast cancer evidence, controversies, consensus - opinion of a german team of experts (zurich 2013).
Michael Untch, Bernd Gerber, Nadia Harbeck, Christian Jackisch, Norbert Marschner, Kurt Possinger

Breast Care (Basel)· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer.
Martin Schuler, Ahmad Awada, Philipp Harter, Jean Luc Canon, Kurt Possinger

Breast Cancer Res Treat· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mTOR inhibitor everolimus in combination with carboplatin in metastatic breast cancer--a phase I trial.
Sandra Schwarzlose-Schwarck, Christian W Scholz, Anne C Regierer, Peter Martus, Christian Neumann, Kurt Possinger

Anticancer Res· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin and the mTOR inhibitor everolimus (RAD001) sensitize breast cancer cells to the cytotoxic effect of chemotherapeutic drugs in vitro.
Hongyu Liu, Christian Scholz, Chuanbing Zang, Jan H Schefe, Piet Habbel, Kurt Possinger

Anticancer Res· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary tumor excision in stage IV breast cancer at diagnosis without influence on survival: a retrospective analysis and review of the literature.
Marleen Rosche, Anne-Constanze Regierer, Sandra Schwarzlose-Schwarck, Andrea Weigel, Nikola Bangemann, Kurt Possinger

Onkologie· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
5
5FU continuous infusion in heavily pretreated advanced breast cancer patients.
Anne C Regierer, Franziska Reinecke, Andrea Weigel, Annette Dieing, Silvia Lehenbauer-Dehm, Kurt Possinger

Onkologie· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast Cancer-Associated Thrombotic Microangiopathy.
Anne C Regierer, Dagmar Kuehnhardt, Carsten-Oliver Schulz, Bernd Flath, Christian F Jehn, Kurt Possinger

Breast Care (Basel)· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the tyrosine kinase inhibitor lapatinib on CUB-domain containing protein (CDCP1)-mediated breast cancer cell survival and migration.
Jeanette Seidel, Klaudia Kunc, Kurt Possinger, Christian Jehn, Diana Lüftner

Biochem Biophys Res Commun· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Simultaneous Inhibition of Estrogen Receptor and the HER2 Pathway in Breast Cancer: Effects of HER2 Abundance.
Anna Emde, Georg Mahlknecht, Kerstin Maslak, Benjamin Ribba, Michael Sela, Kurt Possinger

Transl Oncol· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mTOR inhibitor RAD001 sensitizes tumor cells to the cytotoxic effect of carboplatin in breast cancer in vitro.
Hongyu Liu, Chuanbing Zang, Jan-Hendrik Schefe, Sandra Schwarzlose-Schwarck, Anne-Constanze Regierer, Kurt Possinger

Anticancer Res· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of IL-6, hypothalamus-pituitary-adrenal axis function, and depression in patients with cancer.
Christian Friedrich Jehn, Dagmar Kühnhardt, Andrea Bartholomae, Sebastian Pfeiffer, Peter Schmid, Kurt Possinger

Integr Cancer Ther· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness analysis of anastrozole versus tamoxifen in adjuvant therapy for early-stage breast cancer - a health-economic analysis based on the 100-month analysis of the ATAC trial and the German health system.
Michael P Lux, Achim Wöckel, Agnes Benedict, Stefan Buchholz, Noémi Kreif, Kurt Possinger

Onkologie· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic implication of BAL in patients with neutropenia.
Dagmar Kuehnhardt, Manja Hannemann, Bernd Schmidt, Ulrike Heider, Kurt Possinger

Ann Hematol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Induction of endoplasmic reticulum stress response by TZD18, a novel dual ligand for peroxisome proliferator-activated receptor alpha/gamma, in human breast cancer cells.
Chuanbing Zang, Hongyu Liu, Janina Bertz, Kurt Possinger, H Phillip Koeffler

Mol Cancer Ther· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compound 48, a novel dual PPAR alpha/gamma ligand, inhibits the growth of human CML cell lines and enhances the anticancer-effects of imatinib.
Janina Bertz, Chuanbing Zang, Hongyu Liu, Marlies Wächter, Kurt Possinger

Leuk Res· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
Hongyu Liu, Chuanbing Zang, Anna Emde, Maricarmen D Planas-Silva, Marleen Rosche, Kurt Possinger

Eur J Pharmacol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT.
Stephen Chia, William Gradishar, Louis Mauriac, Jose Bines, Frederic Amant, Kurt Possinger

J Clin Oncol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis